Italy's medical device industry is facing significant challenges that could impact its competitiveness and sustainability.
The current payback system, which requires companies to reimburse the National Health Service for exceeding budgetary limits, is seen as a hindrance to innovation and needs to be eliminated. The president of Confindustria Medical Devices, Nicola Barni, argues for a new governance model that aligns spending ceilings with the European average to foster growth.
Italy's medical device sector is also facing increasing competition from the United States and China, who are investing heavily in research and development. The current regulatory environment adds to the industry's challenges, and Barni calls for a supportive framework that encourages innovation while ensuring safety and efficacy.
The National Health Technology Assessment (HTA) Plan, along with industrial policies, can create a more equitable and sustainable model in the healthcare sector. The economic implications of maintaining the status quo are significant, with potential GDP losses and threats to the broader economic landscape.
The cancellation of the payback system is crucial for the long-term viability of the medical device industry. A cohesive strategy that prioritizes innovation and supports the industry is needed to reclaim Italy's competitive edge in the global market.